Janux Therapeutics, Inc.

JANX · Healthcare

$18.89

Capitalizzazione: 1.15B USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Janux Therapeutics, Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

The Fly24 ago 2026, 13:54

Chipotle downgraded, Darden upgraded: Wall Street's top analyst calls

24/7 Wall St.24 ago 2026, 11:49

Here Are Monday’s Top Wall Street Analyst Research Calls: AstraZeneca, Celestica, Chipotle Mexican Grill, Domino’s Pizza, Fortune Brands, Golar LNG, Jersey Mike’s Subs, Roku, and More

Simply Wall St.11 ago 2026, 10:10

Janux Therapeutics (JANX) Is Up 7.1% After Reporting Narrower Net Losses And Improved Earnings Profile

MT Newswires10 ago 2026, 11:21

RBC Adjusts Price Target on Janux Therapeutics to $34 From $30, Maintains Outperform Rating